NAT BIOLOG STANDARDS BOARD has a total of 26 patent applications. Its first patent ever was published in 1983. It filed its patents most often in United Kingdom, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are INT CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY, THE GOVERNMENT OF THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES and XANTOS BIOMEDICINE AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 13 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | China | 2 | |
#5 | Canada | 1 | |
#6 | Denmark | 1 | |
#7 | New Zealand | 1 | |
#8 | United States | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology | |
#4 | Machines | |
#5 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Minor Philip David | 5 |
#2 | Schild Geoffrey Christopher | 5 |
#3 | Evans David Meurig Ashton | 4 |
#4 | Hawkins John Ross | 4 |
#5 | Almond Jeffrey William | 4 |
#6 | Macadam Andrew | 3 |
#7 | Meager Anthony | 1 |
#8 | Almond J W | 1 |
#9 | Barrowcliffe Trevor William | 1 |
#10 | Ross Hawkins John | 1 |
Publication | Filing date | Title |
---|---|---|
GB0816284D0 | Vaccine | |
GB0812755D0 | Stimulated cell standards | |
GB0812757D0 | Cell profliferation standards | |
GB0611821D0 | Proteomics analysis | |
GB0611839D0 | Proteomics analysis | |
GB0328451D0 | Genetic reference materials | |
GB0328595D0 | Genetic reference materials | |
GB0015921D0 | Improvements in or relating to stabilisation of substances | |
GB9818966D0 | Immobilisation of monolayers in a boric acid containing buffer | |
GB9804919D0 | Improvements in or relating to immobilisation of cells | |
GB9718546D0 | Improvements in or Relating to Immobilisation of Cells | |
GB8329700D0 | Anti-haemophilic compositions | |
ZA8307564B | Polypeptides useful in vaccination against enteroviruses |